“The thought [for transperineal biopsy] is that if you can avoid introducing some rectal bacteria into the tissue, that we may be able to totally avoid or at least minimize the post-biopsy infections,” says Badar M. Mian, MD, FACS.
In this video, Badar M. Mian, MD, FACS, discusses the advantages and disadvantages of 2 types of approaches to prostate biopsy: transrectal biopsy, the current standard of care, and the newer transperineal technique. Mian is a professor of surgery and urology at Albany Med Urology in Albany, New York.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.